A surprising method that can diagnose stroke risk and prevent cognitive decline
Medical research is becoming more advanced and therefore establishing a more positive prognosis for past illnesses. This time the University of California at Los Angeles (UCLA) in the USA discovered a method that can diagnose stroke risk. The mathematical model he creates establishes a probability estimate obtained from a simple test of people’s blood. This simple technique can save lives in the short and long term by preventing strokes or other types of traumatic brain injuries.
A blood test that can save lives
After several years of research, the University of California, Los Angeles (UCLA) in the USA discovered a method to diagnose the risk of stroke. A method based on a blood test could help determine who is more likely to suffer from cognitive decline or stroke. The study revealing the breakthrough was published in the journal Stroke. He explained that he determined that the concentration of a network of inflammatory molecules in the blood could allow doctors to calculate the level of risk based on the brain’s blood vessels. That is, those elements that most often cause stroke in older people.
Until now, doctors have determined the likelihood of having a stroke using elements such as MRI scans, demographic variables, family history and risk factors, according to Jason Hinman, the study’s lead author. In addition, the expert notes that could only be predicted if the patient had already suffered a stroke stroke or other similar episode. Now he course of action The test is much simpler because it measures the concentration of inflammatory molecules in the blood. Additionally, this study can be performed on patients who have not yet experienced a cerebrovascular event.
Therefore, doctors can assess the risk of those most likely to have a stroke. Researcher Jason Hinman states that “just as cholesterol tests are used to estimate future risk of heart attack, there is no method for estimating future risk of stroke.” “I think that we can do this with something as simple as a blood test which could theoretically provide greater access to the best level of care rather than limiting it to advanced imaging studies and specialist assessments,” says Jason Hinman.
Demonstrative study
The study, conducted by the University of California, Los Angeles (UCLA) in the US, focused on a network of biologically related inflammatory molecules called the “interleukin-18 network.” The network includes signaling molecules and proteins. which are used to fight infections. Additionally, the binding of these molecules can mutate in response to other conditions, such as autoimmune diseases or influenza. The study begins in 2020 when Jason Hinman, along with other researchers at the University of California, identified six molecules in the network to be associated with the presence of vascular lesions in the brain.
Following this discovery, the researcher worked to determine the patient’s risk of stroke. Although the study represents promising progress in stroke prediction, it still remains an unresolved issue. It is not entirely clear whether it can be reduced. or yearn for an assessment that establishes each patient’s risk. According to researcher Jason Hinman, the problem lies in primary care. “That’s what we’re all interested in: preventing stroke before it happens,” he explains.